National Medicaid Reporting Format Needed To Avoid 340B 'Double Dipping' – Manufacturers
This article was originally published in The Pink Sheet Daily
Executive Summary
In response to CMS' proposed rule on Medicaid managed care, biopharma associations say that the only way to avoid Medicaid and 340B 'double dipping' on drug discounts is to require that all state Medicaid programs have a uniform reporting standard for drug utilization data.